ABOUT

Dr. Antony Lighten

BSc, PhD, MB BChir (Cambridge), FRCOG, FRANZCOG, CCSST (UK CREI equiv)

Dr Lighten specialises in all aspects of fertility treatments including IVF & fertility surgery. He has almost 30 years of experience in treating patients in fertility clinics in the UK, Ireland and Australia.

He is doubly qualified as both a medical doctor and a science PhD. With a strong science background, Dr Lighten bases all his treatments on the most up to date scientific evidence.

Dr Lighten is an experienced fertility surgeon specialising in complex surgical procedures which improve the chance of both spontaneous pregnancy and pregnancy after IVF. He performs advanced laparoscopic surgery for endometriosis and hysteroscopic surgery for intra-uterine problems at Northwest Private Hospital.

Outside of medicine, Dr Lighten enjoys being ski touring and cycling. He represented Great Britain at the Junior World Rowing Championship. He also represented the University of London and Cambridge University (Reserve Goldie Crew) at Rowing. He was a reservist medical officer in the British Army for 12 years, serving with the Parachute Regiment. Dr Lighten also worked as a Management Consultant for McKinsey and Co during a break from medical practice.

After 30 years of helping patients build their families, Dr Lighten finally welcomed his first child, baby Kit in 2019.

PHILOSOPHY

“Every person that comes to our clinic comes with their own story, hopes and vision. For that reason, every treatment is unique and personalised to suit . My approach reflects this.”

Dr Lighten found himself in the humbling position of being a fertility patient himself with his wife Cayenne. The years of treatment, struggle and pain finally led to baby Kit. This experience has had a profound effect on the way he approaches his patient’s journey.

 

Dr Lighten knows that undergoing fertility treatment can be an anxious and stressful time. His team will guide and support you throughout your journey whilst ensuring that they deliver first class clinical results.

QUALIFICATION & EXPERIENCE

Originally from Chester in the United Kingdom, Dr Lighten graduated from Cambridge University Medical School. His first post as a fertility doctor was working for Prof. Lord Robert Winston at the Hammersmith Hospital in London. At that time, Lord Winston was the UK’s pre-eminent Fertility Specialist and his research team led by Prof. Alan Handyside had just become the first in the world to perform preimplantation genetic diagnosis (PGD).

Dr Lighten became Lord Winston’s Research Fellow. His research, although rather esoteric 20 years ago, has become highly relevant. Dr Lighten was the first scientist to demonstrate genomic imprinting in human embryos. Disruption of this imprinting process by IVF culture is now much studied and is known to be the cause of rare genetic conditions that can cause overgrowth syndromes and cancers.

Dr Lighten also demonstrated the importance of insulin-like growth factors in human embryo development. The study of growth factors is now at the forefront of embryology research as researchers look for ways to improve IVF outcomes.

Dr Lighten was awarded the prize for the most promising young scientist by the European Society of Human Reproduction and Endocrinology (ESHRE) in 1997 for his research in genetics and embryo development. This publication continues to be cited in research papers today. In 1998, Dr Lighten was awarded a PhD at Imperial College in London. His work was published in leading journals including Nature Genetics.

Dr Lighten completed his specialist training in London and is a Fellow of the Royal College of Obstetricians and Gynaecologists. Further studies at the Oxford University Fertility Unit led to him completing sub-specialist training in Reproductive Medicine and Surgery (CCSST) which is the UK equivalent of the CREI.

At Oxford, Dr Lighten jointly led an important multi-centre randomised clinical trial into the role of metformin in women with polycystic ovaries having IVF. This research was recognised with prizes from the British Fertility Society (BFS) and the American Society for Reproductive Medicine (ASRM).